Attached files
| file | filename |
|---|---|
| 8-K - ALLIANCE FORM 8-K - BioCube, INC. | form8k.htm |
| EX-10.1 - EXHIBIT 10.1 - BioCube, INC. | ex101.htm |
| EX-17.2 - EXHIBIT 17.2 - BioCube, INC. | ex172.htm |
| EX-99.1 - EXHIBIT 99.1 - BioCube, INC. | ex991.htm |
| EX-17.1 - EXHIBIT 17.1 - BioCube, INC. | ex171.htm |
EXHIBIT 99.2
UNAUDITED FINANCIAL STATEMENTS OF BIOCUBE, INC.
SIX MONTHS ENDED JUNE 30, 2010 AND 2009
BIOCUBE, INC.
(A Development Stage Company)
BALANCE SHEETS
JUNE 20, 2010 AND 2009
|
ASSETS
|
||||||||
|
June 30,
|
June 30,
|
|||||||
|
2010
|
2009
|
|||||||
|
CURRENT ASSETS
|
||||||||
|
Cash
|
$ | 3,287 | $ | 0 | ||||
|
Total Current Assets
|
3,287 | 0 | ||||||
|
PROPERTY AND EQUIPMENT
|
||||||||
|
Decontamination system
|
27,750 | 30,000 | ||||||
|
Total Property and Equipment
|
27,750 | 30,000 | ||||||
|
TOTAL ASSETS
|
31,037 | 30,000 | ||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts Payable
|
43,250 | 13,300 | ||||||
|
Accrued salaries
|
225,000 | 90,000 | ||||||
|
Due to Shareholder
|
1,500 | 0 | ||||||
|
Other accrued expenses
|
865 | 0 | ||||||
|
Short term loans
|
14,175 | 0 | ||||||
|
Total Current Liabilities
|
284,790 | 103,300 | ||||||
|
LONG-TERM LIABILITIES
|
||||||||
|
Note payable Leaddog
|
10,000 | 0 | ||||||
|
Total Long-Term Liabilities
|
10,000 | 0 | ||||||
|
Total Liabilities
|
294,790 | 103,300 | ||||||
|
STOCKHOLDERS' EQUITY
|
||||||||
|
Capital Stock
|
4,500 | 4,500 | ||||||
|
Additonal paid-in capital
|
29,500 | 29,500 | ||||||
|
Retained Earnings
|
(297,753 | ) | (107,300 | ) | ||||
|
Total Stockholders' Equity
|
(263,753 | ) | (73,300 | ) | ||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
31,037 | 30,000 | ||||||
1
BIOCUBE, INC.
(A Development Stage Company)
INCOME STATEMENTS
JUNE 20, 2010 AND 2009
|
Six Months ended
Jun 30, 2010
|
Six Months ended
Jun 30, 2009
|
|||||||
|
REVENUE
|
||||||||
|
Total Revenue
|
$ | 0 | $ | 0 | ||||
|
OPERATING EXPENSES
|
||||||||
|
Amortization
|
750 | 0 | ||||||
|
Bank Service Charges
|
117 | 0 | ||||||
|
Consulting expense
|
15,000 | 10,000 | ||||||
|
Interest Expense
|
596 | 0 | ||||||
|
Officer salaries
|
45,000 | 90,000 | ||||||
|
Rent Expense
|
1,650 | 3,300 | ||||||
|
Total Operating Expenses
|
63,113 | 103,300 | ||||||
|
Operating Income (Loss)
|
(63,113 | ) | (103,300 | ) | ||||
|
OTHER INCOME AND EXPENSE
|
0 | 0 | ||||||
|
Income (Loss) Before Income Taxes
|
(63,113 | ) | (103,300 | ) | ||||
|
Provision for Income Tax
|
0 | 0 | ||||||
|
Net Income (Loss)
|
$ | (63,113 | ) | $ | (103,300 | ) | ||
2
BIOCUBE, INC.
(A Development Stage Company)
STATEMENTS OF CASH FLOW
JUNE 20, 2010 AND 2009
|
Six Months ended
Jun 30, 2010
|
Six Months ended
Jun 30, 2009
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
|
NET INCOME
|
||||||||
|
Net Income (Loss)
|
$ | (63,113 | ) | $ | (103,300 | ) | ||
|
Total Net Income
|
(63,113 | ) | (103,300 | ) | ||||
|
ADJUSTMENTS TO NET INCOME
|
||||||||
|
Adjustments to reconcile Net Income (Loss) to net Cash:
|
||||||||
|
Increase (Decrease) in:
|
||||||||
|
Accounts Payable
|
16,650 | 13,300 | ||||||
|
Accrued salaries
|
45,000 | 90,000 | ||||||
|
Due to Shareholder
|
1,500 | 0 | ||||||
|
Other accrued expenses
|
596 | 0 | ||||||
|
Total Adjustments
|
63,746 | 103,300 | ||||||
|
Net Cash Provided By (Used In) Operating Activities
|
633 | 0 | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
|
Decontamination system
|
750 | (30,000 | ) | |||||
|
Net Cash Provided By (Used In) Investing Activities
|
750 | (30,000 | ) | |||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Capital Stock
|
0 | 30,000 | ||||||
|
Net Cash Provided By (Used In) Financing Activities
|
0 | 30,000 | ||||||
|
NET INCREASE (DECREASE) IN CASH
|
1,383 | 0 | ||||||
|
CASH AT BEGINNING OF PERIOD
|
1,904 | 0 | ||||||
|
CASH AT END OF PERIOD
|
3,287 | 0 | ||||||
3